HBV RNA, HBcrAg, and HBsAg levels at year 6 do not predict HCC risk in patients with cirrhosis on long-term entecavir therapy.
- DOI
- 10.1007/s12072-026-11137-w
- Published
- 2026 Aug 8
- Container
- Hepatology international
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12072-026-11137-w,
title = {HBV RNA, HBcrAg, and HBsAg levels at year 6 do not predict HCC risk in patients with cirrhosis on long-term entecavir therapy.},
author = {Pan HH and Su TH and Hu TH and Chuang WL and Su WW and Lin CC and Peng CY and Wang CC and Hsu YC and Huang YW and Tseng KC and Lin CL and Yang SS and Suk FM and Hsu SJ and Chen TM and Bair MJ and Lin CK and Tseng TC and Kao JH and C-TEAM study group and the Taiwan Liver Diseases Consortium},
year = {2026},
journal = {Hepatology international},
doi = {10.1007/s12072-026-11137-w},
url = {https://doi.org/10.1007/s12072-026-11137-w}
}RIS
TY - JOUR TI - HBV RNA, HBcrAg, and HBsAg levels at year 6 do not predict HCC risk in patients with cirrhosis on long-term entecavir therapy. AU - Pan HH AU - Su TH AU - Hu TH AU - Chuang WL AU - Su WW AU - Lin CC AU - Peng CY AU - Wang CC AU - Hsu YC AU - Huang YW AU - Tseng KC AU - Lin CL AU - Yang SS AU - Suk FM AU - Hsu SJ AU - Chen TM AU - Bair MJ AU - Lin CK AU - Tseng TC AU - Kao JH AU - C-TEAM study group and the Taiwan Liver Diseases Consortium PY - 2026 JO - Hepatology international DO - 10.1007/s12072-026-11137-w UR - https://doi.org/10.1007/s12072-026-11137-w ER -
APA
HH, P., TH, S., TH, H., WL, C., WW, S., CC, L., CY, P., CC, W., YC, H., YW, H., KC, T., CL, L., SS, Y., FM, S., SJ, H., TM, C., MJ, B., CK, L., TC, T., JH, K., & Consortium, C. S. G. A. T. T. L. D. (2026). HBV RNA, HBcrAg, and HBsAg levels at year 6 do not predict HCC risk in patients with cirrhosis on long-term entecavir therapy.. Hepatology international. https://doi.org/10.1007/s12072-026-11137-w
Source records
- pubmed · retrieved 2026-09-25T08:54:18.398Z